Antonio Costa active positions
| Companies | Position | Start | End |
|---|---|---|---|
Diant Pharma, Inc.
 Diant Pharma, Inc. BiotechnologyHealth Technology Diant Pharma, Inc. is a company that specializes in nanoparticle formulation and offers services related to cGMP design, process analytical technology (PAT) integration, and other nanoparticle-related services. The company is based in Manchester, CT. The company's benchtop LARU is a laboratory nanoparticle synthesis system suitable for R&D, academic work, and training operations. DIANT® Pharma was formed in 2019 and emerged from years of rigorous research at the University of Connecticut, resulting in differentiated, innovative continuous processing technologies for nanoparticle-based therapeutics and vaccines. The company was founded in 2019 by Diane Burgess, Antonio Costa. Antonio Costa has been the CEO since 2019. | Chief Executive Officer | 2018-12-31 | - |
| Founder | 2018-12-31 | - |
Career history of Antonio Costa
Statistics
International
| United States | 2 |
Operational
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Diant Pharma, Inc.
Diant Pharma, Inc. BiotechnologyHealth Technology Diant Pharma, Inc. is a company that specializes in nanoparticle formulation and offers services related to cGMP design, process analytical technology (PAT) integration, and other nanoparticle-related services. The company is based in Manchester, CT. The company's benchtop LARU is a laboratory nanoparticle synthesis system suitable for R&D, academic work, and training operations. DIANT® Pharma was formed in 2019 and emerged from years of rigorous research at the University of Connecticut, resulting in differentiated, innovative continuous processing technologies for nanoparticle-based therapeutics and vaccines. The company was founded in 2019 by Diane Burgess, Antonio Costa. Antonio Costa has been the CEO since 2019. | Health Technology |
- Stock Market
- Insiders
- Antonio Costa
- Experience
